Responsibility 02.02.2023
Fortune 500 companies like Amgen spend billions of dollars every year with outside suppliers – very few of which are currently minority owned. Now, Amgen and several other leading companies are investing a total of $1.45 billion in an effort to change that.
Press Release 02.02.2023
Press Release 01.31.2023
Patients 01.31.2023
Patients 01.24.2023
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
